MEDB-56. POx NPs mediated delivery of (TLR7/8) agonist resiquimod improves treatment outcomes in SHH medulloblastoma by targeting tumor associated macrophages

Cancer immunotherapy, the utilization of the patients’ own immune system to treat cancer, has emerged as a powerful new strategy in cancer treatment. Recent clinical data has demonstrated immunotherapy to be effective in a wide range of cancers, including lung, bladder, renal cell, colorectal, gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Duhyeong, Alicea, Coral del Mar, Lim, Chaemin, Park, Christopher, Gershon, Timothy, Sokolsky-Papkov, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medulloblastoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165126/
http://dx.doi.org/10.1093/neuonc/noac079.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165126/
http://dx.doi.org/10.1093/neuonc/noac079.430

Ejemplares similares